Cargando…
Local Delivery of Minocycline and Vorinostat Targets the Tumor Microenvironment to Inhibit the Recurrence of Glioma
BACKGROUND: Postoperative recurrence is the main reason for poor clinical outcomes in glioma patients, so preventing tumor recurrence is crucial in the management of gliomas. METHODS: In this study, the expression of matrix metalloproteinases (MMPs) in normal tissues was detected via RNA-seq analysi...
Autores principales: | Zhao, Gang, Jia, Jun, Wang, Lansheng, Zhang, Yongkang, Yang, Han, Lu, Yang, Yu, Rutong, Liu, Hongmei, Zhu, Yufu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655508/ https://www.ncbi.nlm.nih.gov/pubmed/33192073 http://dx.doi.org/10.2147/OTT.S273527 |
Ejemplares similares
-
Multi-responsive nanofibers composite gel for local drug delivery to inhibit recurrence of glioma after operation
por: Zhu, Yufu, et al.
Publicado: (2021) -
Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration
por: Wolf, Ines M. L., et al.
Publicado: (2014) -
The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
por: Xu, Haoyue, et al.
Publicado: (2022) -
Vorinostat—An Overview
por: Bubna, Aditya Kumar
Publicado: (2015) -
Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma
por: Ghiaseddin, Ashley, et al.
Publicado: (2017)